Opioids Market – Increasing research into new developments through new drug development is expected to drive market growth

0

Opioids are psychoactive substances known to be opiates or have opioid-like effects. Fentanyl, alphamethylfentanyl, alfentanil, and sufentanil are some of the examples of synthetic opioids.

Key players in the world opioid market focus on adopting collaboration and partnership strategies to increase their market share. For example, in January 2018, Depomed, Inc. signed an agreement with Collegium Pharmaceutical Inc. for the commercialization of NUCYNTA Extended Release and NUCYNTA Immediate Release for the management of short-term (acute) pain in adults in the United States. .

PDF brochure sample request:
https://www.coherentmarketinsights.com/insight/request-sample/1017

The increasing prevalence of chronic diseases is expected to propel the growth of the global opioids market during the forecast period. For example, according to the American Cancer Society, in 2020, approximately 276,480 new cases of invasive breast cancer will be diagnosed in women, and the disease will result in approximately 42,170 deaths, in the United States.

Moreover, the increasing number of emergency surgeries is also expected to contribute to the growth of the market. For example, according to the 2017-2018 report from the Australian Institute of Health and Welfare’s Hospital, updated in August 2019, emergency surgery admissions increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and 5.1% in private hospitals. in Australia.

Funding for opioid R&D is expected to provide lucrative growth opportunities for players in the global opioid market. For example, in the United States, the National Institute on Drug Abuse (NIDA) provides funding for R&D on drug use and its consequences.

The global opioid market is estimated to be worth US $ 51,005.8 million in value by the end of 2027. Market growth is driven by the approval and launch of new products. For example, in November 2018, the United States Food and Drug Administration approved DSUVIA from AcelRx Pharmaceuticals, Inc. for use in adults in health facilities certified to be medically supervised for the management of acute pain severe enough. to require an opioid pain reliever.

The North America region held a dominant position in the global opioid market in 2018, with a share of 64.8% by volume, followed by Europe.

The morphine segment in the global opioid market was valued at US $ 13,697.6 million in 2018 and is expected to reach US $ 17,766.2 million by 2027 at a CAGR of 2.9% over the course of the forecast period.

Get a PDF brochure for more information
https://www.coherentmarketinsights.com/insight/request-pdf/1017

The use of synthetic opioids can lead to several side effects thus hampering the growth of the global opioid market. For example, remifentanil causes reduced sympathetic nervous system tone, respiratory depression, and analgesia.

Moreover, the increase in drug overdose cases is also expected to hamper the growth of the market. For example, according to the 2018 National Survey on Drug Use and Health, in the United States, approximately 164.8 million people aged 12 or older in the United States were addicted to drugs in the past month, especially tobacco, alcohol or illicit drugs.

The major players operating in the global opioids market are Actavis Plc., Boehringer Ingelheim, Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Pfizer, Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd. and Zyla Life Sciences.

The major players operating in the global opioid market are focusing on R&D to expand their product portfolio. For example, in August 2021, Averitas Pharma Inc., the US subsidiary of Grünenthal, enrolled the first patient in AV001, a phase III study that evaluates the efficacy, safety and tolerability of the QUTENZA (capsaicin) topical system. at 8% in post-processing. -surgical neuropathic pain.

Reasons to buy this report

• Current and future outlook of the global opioid market in developed and emerging markets.

• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.

• Regions / countries expected to experience the fastest growth rates during the forecast period

• The latest developments, market shares and strategies used by the main market players

Buy this full activity report with a discount of US $ 2000 @

Contents

  1. Research objectives and hypotheses
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market Snapshot
    • Description of the report
      • Definition and scope of the market
    • Abstract
      • Market extract, by product type
      • Market extracts, by application
      • Market extract, by region
      • Coherent Opportunity Map (COM)
  3. Analysis of market dynamics, regulations and trends
    • Market dynamics
      • Conductors
      • Constraints
      • Market opportunities
    • Impact analysis
    • Highlights
    • Product launch
    • PEST analysis
    • Regulatory scenario
    • Mergers and Acquisitions
  4. Global Opioid Market, By Product Type, 2019-2027, (USD Million)
    • introduction
      • Market share analysis, 2019 and 2027 (%)
      • Year-on-year growth analysis, 2017 – 2027
      • Segment trends
    • Morphine
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Codeine
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Fentanyl
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Meperidine
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Methadone
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
  5. Global Opioid Market, By Application, 2019-2027, (USD Million)
    • Analgesia
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Cough suppression
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
    • Suppression of diarrhea
      • introduction
      • Market Size and Forecast, and Year-on-Year Growth, 2016-2027, (USD Million)
  6. Global Opioids Market, By Region, 2019-2027, (Million US $)
    • introduction
      • Market share analysis, by region, 2019 and 2027 (%)
      • Year-on-year growth analysis, for regions, 2017-2026
    • North America
      • Market Size and Forecast, by Product Type, 2016-2027, (USD Million)
      • Market Size and Forecast, by End User, 2016 – 2027, (USD Million)
      • Market Size and Forecast, by Country, 2016-2027, (USD Million)
    • Latin America
      • Market Size and Forecast, by Product Type, 2016-2027, (USD Million)
      • Market Size and Forecast, by End User, 2016 – 2027, (USD Million)
      • Market Size and Forecast, by Country, 2016-2027, (USD Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, by Product Type, 2016-2027, (USD Million)
      • Market Size and Forecast, by End User, 2016 – 2027, (USD Million)
      • Market Size and Forecast, by Country, 2016-2027, (USD Million)
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Russia
        • The rest of europe
    • Asia Pacific
      • Market Size and Forecast, by Product Type, 2016-2027, (USD Million)
      • Market Size and Forecast, by End User, 2016 – 2027, (USD Million)
      • Market Size and Forecast, by Country, 2016-2027, (USD Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of the APAC
    • Middle East
      • Market Size and Forecast, by Product Type, 2016-2027, (USD Million)
      • Market Size and Forecast, by End User, 2016 – 2027, (USD Million)
      • Market Size and Forecast, by Country, 2016-2027, (USD Million)
        • CCG
        • Israel
        • Rest of the Middle East
    • Africa
      • Market Size and Forecast, by Product Type, 2016-2027, (USD Million)
      • Market Size and Forecast, by End User, 2016 – 2027, (USD Million)
      • Market Size and Forecast, by Country, 2016-2027, (USD Million)
        • South Africa
        • central Africa
        • North Africa
  7. Competitive landscape
    • Company Profiles
      • Pfizer Inc.
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Boehringer Ingelheim
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Janssen Pharmaceuticals, Inc.
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Actavis Plc.
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Sanofi SA
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Mallinckrodt Pharmaceuticals
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Endo Pharma inc.
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
      • Zyla Life Sciences
        • Company presentation
        • Product portfolio
        • Financial overview
        • Highlights
        • Market strategies
  8. Section
    • The references
    • Research methodology
    • About us and commercial contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office in India, an office at Global Financial Capital in the United States, and business consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients of all backgrounds, from Fortune 500 companies to nonprofits and startups looking to enter the market. We excel in providing unmatched actionable market insights across various industry verticals including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, customized research solutions and advisory services.

Contact:

Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837


Source link

Leave A Reply

Your email address will not be published.